HomeVVOS • NASDAQ
add
Vivos Therapeutics Inc
Previous close
$2.64
Day range
$2.60 - $2.70
Year range
$2.40 - $48.79
Market cap
7.24M USD
Avg Volume
282.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 3.25M | -17.77% |
Operating expense | 6.22M | -26.34% |
Net income | -4.26M | 30.05% |
Net profit margin | -131.13 | 14.93% |
Earnings per share | -2.76 | 44.87% |
EBITDA | -3.98M | 32.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.64M | -53.31% |
Total assets | 10.73M | -21.79% |
Total liabilities | 10.32M | 15.70% |
Total equity | 411.00K | — |
Shares outstanding | 2.73M | — |
Price to book | 12.00 | — |
Return on assets | -98.18% | — |
Return on capital | -453.58% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.26M | 30.05% |
Cash from operations | -2.75M | 8.40% |
Cash from investing | -165.00K | 17.50% |
Cash from financing | 3.57M | — |
Net change in cash | 655.00K | 120.47% |
Free cash flow | -2.07M | -148.88% |
About
Founded
2016
Headquarters
Website
Employees
119